William E. Evans, Pharm.D.
Dr. William E. Evans is Director and Chief Executive Officer of St. Jude Children's Research Hospital (SJCRH), and holds the St. Jude Professorship and Endowed chair at the University of Tennessee Colleges of Medicine and Pharmacy.
For the past 30 years, his research at St. Jude has focused on the pharmacogenomics of anticancer agents in children, for which he has received three consecutive NIH MERIT Awards from the National Cancer Institute. The major disease focus of his pharmacogenomics research is acute lymphoblastic leukemia in children.
He is a member of the Board of Directors of Methodist Le Bonheur Healthcare, the Board of Trustees of Rhodes College, the Board of Directors of the Memphis Chamber of Commerce, and the Board of Directors of the Tennessee Technology Development Corporation. He currently serves on several Scientific Advisory Boards including the Board of Scientific Counselors for the US National Cancer Institute of NIH, and the International Advisory Council for the Singapore Agency of Science, Technology and Research.
Dr. Evans has authored over 300 articles and numerous book chapters, has been the editor of several textbooks and scientific journals, and has received several national awards for his research. He is recognized by ISI as a “Highly Cited Scientist” because citations of his publications are among the top one-half percentile of scientists worldwide in his field. He was elected to the Institute of Medicine of the National Academy of Sciences in 2002.